Covid-19 and Parkinsonism, Volume 165 in the International Review in Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters that cover a variety of topics, including Parkinsonism associated with viral infections, Covid-19 and nervous system pathology: bench to bedside, Prevalence of Covid-19 in Parkinson's Disease: acute settings and hospital, Covid-19 and Parkinson's Disease: clinical features, long COVID, Smell deficits in Covid-19 and possible links with Parkinson's Disease, Spotlight on non-motor symptoms and Covid-19, and a Summary of treatment paradigms in Parkinson's Disease patients and Covid-19. Additional sections cover Covid-19 and Parkinson's Disease: nursing care, vaccination, telemedicine services, impact on advanced therapies, Covid-19-induced parkinsonism: Real life phenoconversion cases, Loneliness and impact of lockdown on Parkinson's Disease patients during the Covid-19 pandemic, Parkinson's Disease and Covid-19: Impact of ethnicity and palliative care, and more.

Although briefly covered in neurology texts, until now there has been no professional-level publication dedicated solely to restless legs syndrome (RLS). Written by a panel of experts, Restless Legs Syndrome focuses on the diagnosis and management of RLS. The authors discuss the epidemiology of RLS, pathophysiology and clinical associations, and clinical features. They also explore how to correctly diagnose the many different types of patients who present with this disorder. Its discussions of the wide range of treatment options available gives clinicians the information they need to formulate appropriate pharmacological or non-pharmacological therapeutic regimens.

Handbook of Non-Motor Symptoms in Parkinson's Disease is designed to provide practical tips and emphasize key priorities for treatment of non-motor aspects of the disorder. The quick-reference handbook format, with key points highlighted by the use of figures and tables, will provide the reader with high-value practical information.

The book provides an overview of the whole field of movement disorders by two recognised experts.

Written by well known authors, one European and one from USA
Whole field covered in concise pocket-sized format
Practical guidefor use in the clinic"

Non-motor Parkinson's: The Hidden Face-Management and the Hidden Face of Related Disorders, Volume 134, the latest release in the International Review of Neurobiology series, is an up-to-date and comprehensive textbook addressing non-motor aspects of Parkinson's disease, a key unmet need. Specific chapters in this updated release include Therapeutics and NMS in PD, Non-motor effects of conventional and transdermal therapies in PD, Infusion therapy, CDD and NMS in PD, DBS and NMS in PD, TMS and implications for NMS in PD, Botulinum toxin therapy and NMS in PD, and Nutrition and NMS in PD, amongst others. Including practical tips for non-specialists and clinical algorithms, the book contains contributions from over 40 opinion leaders in the field of movement disorders. It provides practitioners and researchers with a laboratory, to bedside, to caregiver perspective.

Parkinson's Disease, Volume 132 addresses new developments in the F33 study of this disease, highlighting how the lives of people with Parkinson's have undergone dramatic changes in the last decade. New to this edition are chapters on the Hallmarks of clinical aspects PD throughout centuries, The motor syndrome of Parkinson disease, The non-motor features of Parkinson's disease, The New Diagnostic Criteria for Parkinson's disease, Advances in the Clinical Differential diagnosis, Clinical assessments in PD : Scales and monitoring, Biomarkers of Parkinson's disease: an Introduction, and the Genetics of Parkinson's Disease: Genotype-Phenotype Correlations. The topics discussed in this comprehensive series provide a clearer understanding of the prodromal stage, genetics, strategies, routes of treatment, and development of non-dopaminergic therapies in Parkinson's Disease, both medical and surgical.

Non-motor Parkinson's: The Hidden Face, Volume 133, the first part of the latest volume in the International Review of Neurobiology series, is an up-to-date, comprehensive textbook addressing the non-motor aspects of Parkinson's disease, a key unmet need. Chapters in this new release include topics such as The hidden face of Parkinson's, JP and non-motor symptoms, Parkinson's: a complex non-motor disease, Neuropathology of NMS of PD, Neurophysiology and animal models related to NMS in PD, Epidemiology of NMS in PD (cohort studies), Genes and NMS in PD, NMS in genetic forms of PD, and Imaging the NMS in PD. Including practical tips for non-specialists and clinical algorithms, this book contains contributions from over 40 opinion leaders in the field of movement disorders, covering the topic from laboratory, to bedside, to caregiver.

Sexual Dysfunction in Parkinson's Disease, Volume 182, the latest release in the International Review of Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters on a variety of trending and important topics, including Prevalence, clinical presentations and impact on relationship, Pathophysiology, Scales for assessing sexual dysfunction in Parkinson's disease, Diagnostic work up: Laboratory and biomarkers, Management strategies, ICD DDS and sex dysfunction, Non-motor fluctuations and sex dysfunction, Exploring Sexual Dysfunction in Care Homes, and The impact of non-motor symptoms burden on sexual functions.

* Offers a concise, comprehensive overview of the diagnosis, treatment and management of common and rarer movement disorders * Written by two key international movement disorder experts * Clinically focused and accessible * Provides a practical guide to the assessment of movement disorders where diagnosis relies on examination and observation rather than radiology and serological assessments Movement disorders attack the part of the brain that controls our movements, they are a complex group of disorders, spanning all aspects of neurological illnesses. Such disorders are widespread, often destroying the independence of those affected. Movement Disorders in Clinical Practice provides a concise, practical overview of the diagnosis, treatment and management of patients with these debilitating conditions, including a brief evaluation of ongoing clinical trials. Edited by two key international movement disorder experts, chapters cover: * Parkinson's disease * Parkinsonian syndromes * Dystonia * Tremor * Restless legs syndrome * An overview of other movement disorders

Patients with Parkinson's disease (PD) are known to suffer from motor symptoms of the disease, but they also experience non-motor symptoms (NMS) that are often present before diagnosis or that inevitably emerge with disease progression. The motor symptoms of Parkinson's disease have been extensively researched, and effective clinical tools for their assessment and treatment have been developed and are readily available. In contrast, researchers have only recently begun to focus on the NMS of Parkinson's Disease, which are poorly recognized and inadequately treated by clinicians. The NMS of PD have a significant impact on patient quality of life and mortality and include neuropsychiatric, sleep-related, autonomic, gastrointestinal, and sensory symptoms. While some NMS can be improved with currently available treatments, others may be more refractory and will require research into novel (non-dopaminergic) drug therapies for the future. Edited by members of the UK Parkinson's Disease Non-Motor Group (PD-NMG) and with contributions from international experts, this new edition summarizes the current understanding of NMS symptoms in Parkinson's disease and points the way towards future research.

Parkinson's disease (PD) affects approximately 4 million people globally and is most commonly seen in people over the age of 50. The disease is a progressive disorder of the nervous system, and presents a number of movement and cognitive symptoms, thereby greatly affecting a patients quality of life. The use of scales for assessment in neurological disorders such as PD arises from the need to quantify disorders and states (such constructs as disability, symptoms, quality of life). Assessment scales are often categorised into two categories: generic (ie. those scales usable in any health condition), and specific (ie. scales developed for exclusive use in PD). They can have a variety of components: single-item and multi-item or composite scale; unidimensional and multidimensional; and as disease-centered and patient-centered measures. The creation and validation of scales is complex, with scales undergoing numerous studies to assess criteria such as acceptability, reliability, and responsiveness. In the process of validation of a scale the following attributes should be tested to ascertain whether a scale is an effective instrument of measurement. This Guide assesses the key clinimetric attributes in the assessment of PD, with the intention to offer rapid and pragmatic information on the most relevant scales used in PD.